Arcutis' ZORYVE (Roflumilast) Cream 0.3% Added to Express Scripts, Inc. National Formularies in the United States Seite 1
17.11.2022 - ZORYVE is now on formulary for one of the top pharmacy benefit managers serving commercially insured patients, effective November 18, 2022ZORYVE is a once-daily non-steroidal cream and the first and only topical PDE4 inhibitor approved for use in ... Seite 1